Table 1.

Patients’ demographic data.

Characteristics	Intervention n=22	Control n=44	p-value
Average age/years (range)	27.64 (5 - 58)	29.63 (5 - 60)	0.67
Average years of study (range)	7.64 (0 - 19)	6.74 (0 - 15)	0.48
Male (%)	11 (50)	28 (64)	0.31
N° of medicines in use (range)	10 (8 – 12)	10 (8 - 12)	0.99
Poorest SeS (%)	5 (22.7)	12 (27.3)	0.77
Prophylaxis (%)			0.99
Cyclosporine	12 (55)	24(55)
Tacrolimus	10 (45)	20 (45)
Comorbidities(%)	17 (77.3)	31 (70.4)	0.71
Hypertension	11 (50)	20 (45)
Depression	5 (22.7)	11 (25)
Dislipidemia	4 (18)	6 (13.6)
Diabetes Mellitus II	2 (9)	5 (11)
Hepatic disorder	2 (9)	6 (13.6)
Hormonal disorder	2 (9)	4 (9)
Pre-Transplant Place of Residence (%)			0.14
Capital	1 (4.5)	7 (15.9)
Metropolitan area	10 (45.5)	21 (47.8)
Countryside	8 (36.4)	13 (29.5)
Other States	3 (13.6)	3 (6.8)
Residence After Transplant (%)			0.74
Capital	9 (40.9)	18 (15.8)
Metropolitan area	13 (59.1)	24 (54.5)
Other States	0	2 (4.5)

SeS: Socioeconomic Status; Poorest SeS was based on Silla et al.19